Trust Company of Vermont’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Trust Company of Vermont’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-300	Closed	-$28K	–	794
2021 Q4	$28K	Buy	+300	New	+$19.8K	﹤0.01%	551
2021 Q3	–	Sell	-300	Closed	-$20K	–	766
2021 Q2	$20K	Hold	300	–	–	﹤0.01%	560
2021 Q1	$21K	Hold	300	–	–	﹤0.01%	547
2020 Q4	$23K	Hold	300	–	–	﹤0.01%	529
2020 Q3	$22K	Hold	300	–	–	﹤0.01%	521
2020 Q2	$19K	Hold	300	–	–	﹤0.01%	544
2020 Q1	$13K	Hold	300	–	–	﹤0.01%	624
2019 Q4	$14K	Hold	300	–	–	﹤0.01%	672
2019 Q3	$14K	Buy	+300	New	+$16.9K	﹤0.01%	695

Trust Company of Vermont's ARNA Position: Q1 2022 in Review

Trust Company of Vermont sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 300 shares — an estimated $28K sold.

Trust Company of Vermont first reported a position in ARNA in Q3 2019 and held it in 9 quarters. The position peaked at $28K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Trust Company of Vermont reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Trust Company of Vermont sold 300 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $28K.
Trust Company of Vermont first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 9 quarters.
Trust Company of Vermont's Arena Pharmaceuticals Inc position peaked at $28K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Trust Company of Vermont's 13F filing for Q1 2022, filed 5 Apr 2022.